1-9 of 9
A. Engert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HuMax-CD20, a Novel Fully Human Anti-CD20 Monoclonal Antibody: Results of a Phase I/II Trial in Relapsed or Refractory Follicular Non-Hodgkins’s Lymphoma.

A. Hagenbeek, T. Plesner, P. Johnson, L. Pedersen, J. Walewski, A. Hellmann, B. Link, T. Robak, M. Wojtukiewicz, M. Pfreundschuh, M. Kneba, A. Engert, P. Sonneveld, J. Petersen, J. Radford
Journal: Blood
Blood (2005) 106 (11): 4760.
https://doi.org/10.1182/blood.V106.11.4760.4760
Published: 2005
Journal Articles

Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).

Volker Diehl, C. Brillant, J. Franklin, R. Hermann, R. Greil, A. Engert, B. Pfistner, for the German Hodgkin Lymphoma Study Group (GHSG), for the Competence Network Malignant Lymphoma.
Journal: Blood
Blood (2004) 104 (11): 307.
https://doi.org/10.1182/blood.V104.11.307.307
Published: 2004
Journal Articles

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller-Hermelink, R. Herrmann, B. Doerken, L. Kanz, R. Greil, B. Pfistner, for the German Hodgkin′s lymphoma study group (GHSG), the Competence Network Malignant Lymphoma.
Journal: Blood
Blood (2004) 104 (11): 1307.
https://doi.org/10.1182/blood.V104.11.1307.1307
Published: 2004
Journal Articles

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller Hermelink, R. Herrman, J. Markova, A. Ho, W. Hiddemann, B. Doerken, R. Greil, B. Pfistner, for the German Hodgkin′s Lymphoma Study Group (GHSG), the Competence Network Malignant Lymphoma.
Journal: Blood
Blood (2004) 104 (11): 1308.
https://doi.org/10.1182/blood.V104.11.1308.1308
Published: 2004
Journal Articles

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

U. Winkler, M. Jensen, O. Manzke, H. Schulz, V. Diehl, A. Engert
Journal: Blood
Blood (1999) 94 (7): 2217–2224.
https://doi.org/10.1182/blood.V94.7.2217.419k02_2217_2224
Published: 1999
Journal Articles

Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group

H. Tesch, V. Diehl, B. Lathan, D. Hasenclever, M. Sieber, U. Rüffer, A. Engert, J. Franklin, M. Pfreundschuh, K.P. Schalk, G. Schwieder, G. Wulf, G. Dölken, P. Worst, P. Koch, N. Schmitz, U. Bruntsch, C. Tirier, U. Müller, M. Loeffler
Journal: Blood
Blood (1998) 92 (12): 4560–4567.
https://doi.org/10.1182/blood.V92.12.4560
Published: 1998
Journal Articles

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

B. Coiffier, C. Haioun, N. Ketterer, A. Engert, H. Tilly, D. Ma, P. Johnson, A. Lister, M. Feuring- Buske, J.A. Radford, R. Capdeville, V. Diehl, F. Reyes
Journal: Blood
Blood (1998) 92 (6): 1927–1932.
https://doi.org/10.1182/blood.V92.6.1927
Published: 1998
Journal Articles

Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins

U Winkler, C Gottstein, G Schon, U Kapp, J Wolf, ML Hansmann, H Bohlen, P Thorpe, V Diehl, A Engert
Journal: Blood
Blood (1994) 83 (2): 466–475.
https://doi.org/10.1182/blood.V83.2.466.466
Published: 1994
Journal Articles

Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies

H Bohlen, T Hopff, O Manzke, A Engert, D Kube, PD Wickramanayake, V Diehl, H Tesch
Journal: Blood
Blood (1993) 82 (6): 1803–1812.
https://doi.org/10.1182/blood.V82.6.1803.1803
Published: 1993